Page 1 of Clinical Trials for Drug etoposide phosphate, 941 Total Matches
- 1SuspendedLast Updated: September 22, 2011Condition(s): Bone Marrow Suppression; Brain and Central Nervous System Tumors; Drug/Agent Toxicity by Tissue/Organ; Long-term Effects Secondary to Cancer Therapy in Children
- 2TerminatedLast Updated: November 21, 2011Condition(s): Brain and Central Nervous System Tumors; Drug/Agent Toxicity by Tissue/Organ; Lymphoma; Thrombocytopenia
- 3Active, not recruitingLast Updated: April 20, 2012Condition(s): Small Cell Lung Cancer
- 4TerminatedLast Updated: November 4, 2011Condition(s): HER-2 Positive Metastatic Breast Cancer
- 5CompletedLast Updated: January 25, 2010Condition(s): Prostate Cancer
- 6RecruitingLast Updated: February 13, 2012Condition(s): Hodgkin's Disease; Non-Hodgkin's Lymphoma
- 7Not yet recruitingLast Updated: May 2, 2012Condition(s): Small Cell Lung Carcinoma
- 8RecruitingLast Updated: April 13, 2012Condition(s): Neuroblastoma
- 9RecruitingLast Updated: May 9, 2009Condition(s): Drug/Agent Toxicity by Tissue/Organ; Testicular Germ Cell Tumor
- 10RecruitingLast Updated: April 25, 2012Condition(s): Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Minimally Differentiated Myeloid Leukemia (M0); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblastic Leukemia Without Maturation (M1); Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Acute Myelomonocytic Leukemia (M4); Adult Erythroleukemia (M6a); Adult Pure Erythroid Leukemia (M6b); Recurrent Adult Acute Myeloid Leukemia
- 11RecruitingLast Updated: February 29, 2012Condition(s): Recurrent or Refractory Pediatric Ependymoma
- 12RecruitingLast Updated: February 25, 2011Condition(s): Leukemia, Myeloid, Acute
- 13Active, not recruitingLast Updated: February 22, 2010Condition(s): Neuroblastoma
- 14Active, not recruitingLast Updated: May 9, 2009Condition(s): Childhood Germ Cell Tumor; Drug/Agent Toxicity by Tissue/Organ; Extragonadal Germ Cell Tumor; Ovarian Cancer
- 15CompletedLast Updated: May 17, 2011Condition(s): Lymphoblastic Leukemia, Acute, Childhood
- 16Enrolling by invitationLast Updated: February 29, 2012Condition(s): Ependymoma
- 17TerminatedLast Updated: July 22, 2011Condition(s): Lung Cancer; Unspecified Adult Solid Tumor, Protocol Specific
- 18CompletedLast Updated: March 28, 2012Condition(s): Sarcoma, Kaposi; HIV Infections
- 19RecruitingLast Updated: December 6, 2011Condition(s): Unspecified Childhood Solid Tumor, Protocol Specific
- 20CompletedLast Updated: March 3, 2008Condition(s): Adrenal Cortical Carcinoma
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+etoposide+phosphate
